Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Aortic Stent and Vascular Graft devices include Aortic Stent Grafts, Vascular Grafts and Extenders. Vascular grafts are tubes made up of natural tissue or synthetic materials surgically implanted in the veins and arteries. GlobalData uses proprietary data and analytics to provide a comprehensive report on the vascular grafts market in Egypt. Buy the latest report here.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Vascular Grafts are the implants used to repair, bypass or replace sections of blood vessels during surgical procedures. They are also used to patch injured or diseased areas in the arteries and for the replacement of whole segments of larger arteries such as the aorta. Vascular grafts are classified into autografts, allografts and synthetic vascular grafts on the basis of the materials. Autograft vascular grafts are vascular grafts taken from the individual and used in the same individual. These grafts are not tracked in this market. Allograft vascular grafts are vascular grafts taken from another individual and used in the treated patient. Synthetic vascular grafts are the grafts which are manufactured using polymers. Polyester and Polytetrafluoroethylene (PTFE) are the two synthetic materials used to construct synthetic vascular grafts. Synthetic (polyethyleneterepthalate) vascular grafts are made from polymer yarn woven tubes whereas Synthetic PTFE vascular grafts are made by mechanically stretching sheets of polytetrafluoroethylene. Aortic vascular grafts are grafts that are used to replace and repair damaged portions of the aorta. Peripheral vascular grafts are grafts that are used to replace and repair damaged blood vessels outside of the aorta.
The vascular grafts market in Egypt can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size vascular grafts in Egypt, buy the report here.